CellWell record HH-466911
A Comprehensive Systematic Review Comparing Nutraceutical Supplementation (Magnesium, Chromium, Coenzyme Q10, Astaxanthin and Related Agents) on the Lipid Profile, HbA1c and HOMA-IR in Patients with Type 2 Diabetes Mellitus and Dyslipidaemia
Ade Dwirisha Putra; D. A. L. Dewi; Hidayat Wiriantono
The Indonesian Journal of General Medicine · 2026
In plain language
A systematic review of 32 studies in type 2 diabetes with dyslipidaemia found magnesium, chromium, CoQ10 and astaxanthin were each linked to small improvements in lipids, HbA1c or insulin resistance, with non-linear dose-responses.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-466911
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.